TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer

Published:2021-07 Issue: Volume:189 Page:114085
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Tan Ying,Li Xuanna,Tian Zhenfeng,Chen Shangxiang,Zou Jinmao,Lian Guoda,Chen Shaojie,Huang Kaihong,Chen Yinting

Funder

National Natural Science Foundation of China

Guangdong Science and Technology Department

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference43 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet Tieulent J, Jemal A. Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians 2015;65:87-108.

2. Marina Ayres Pereira Iok In Christine Chio Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies Genes 11 1 6 10.3390/genes11010006 https://www.mdpi.com/2073-4425/11/1/6.

3. PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer;Yaghoubi;Biomed Pharm.,2019

4. Pancreatic cancer;Hidalgo;N Engl J Med,2010

5. Understanding Metastasis in Pancreatic Cancer: A Call for New Clinical Approaches;Tuveson;Cell,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing homoharringtonine for thyroid cancer treatment through TIMP1/FAK/PI3K/AKT signaling pathway;iScience;2024-06

2. Tumor Stroma as a Therapeutic Target for Pancreatic Ductal Adenocarcinoma;Biomolecules & Therapeutics;2024-04-10

3. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches;Cancer Letters;2024-04

4. miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment;International Immunopharmacology;2024-03

5. TIMP1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3